急性氧化过量与严重和长期的心脏毒性
William Richardson1,2, Dan Fisher3, Stanley Hassinger1
1Emergency Medicine, Prisma Health Midlands, Columbia, USA.
Cureus
|July 23, 2025
概括
一个过量服用氧化的病例突出了严重的毒性,包括低血压和心律失常. 迅速应急管理流体,通风,和特定的解毒剂导致完全恢复.
科学领域:
- 毒理学 毒理学 毒理学
- 紧急医疗 紧急医疗
- 药理学 药理学是指药理学的学科.
背景情况:
- 尽管尚未证明有效性,但COVID-19后氧化的处方仍然很高.
- 过量服用氧化对紧急情况的管理构成了重大挑战.
研究的目的:
- 描述一个患有大量氧化过量患者的医院管理.
- 突出严重氧化毒性所需的关键干预措施.
主要方法:
- 一个49岁的女性在摄入24克氧化后呈现的病例报告.
- 治疗包括静脉注射液体复苏,机械通风,血管压缩剂,电解质校正,以及输注亚泽,碳酸和利多卡因.
主要成果:
- 患者出现了低血压,心室节律失常 (包括torsades de pointes) 和严重的低血压.
- 积极的医疗管理导致患者在没有神经缺陷的情况下出院.
结论:
- 严重的氧化过量需要在紧急情况下进行密集和多方面的管理.
- 鉴于氧化的持续广泛使用,对氧化毒性的理解和准备至关重要.
相关概念视频
Anticholinesterase Agents: Poisoning and Treatment
1.0K
Anticholinesterases, also known as cholinesterase inhibitors, work by blocking the breakdown of acetylcholine, leading to its accumulation in the synaptic cleft. This accumulation indirectly enhances both muscarinic and nicotinic actions. These agents are classified as reversible or irreversible based on their mechanism of action.
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
1.0K
Cardiomyopathy II: Dilated Cardiomyopathy
23
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
23
Rheumatic Heart Disease I: Introduction
46
Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
46
Cardiomyopathy V: Interprofessional Care
35
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
35
Cardiomyopathy III: Hypertrophic Cardiomyopathy
52
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
52
Heart Failure Drugs: Inotropic Agents
732
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
732


